← Back to Search

Researcher-Group for Genetic Predisposition

N/A
Waitlist Available
Research Sponsored by State University of New York at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
40 years of age and older
Live in predominately African American communities (ZIP codes)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post intervention
Awards & highlights

Study Summary

The overall goal of this study is to reduce breast cancer morbidity and mortality disparities among African American women by actively engaging family history as a tool to modify screening regimens and enhance communication between women and their providers. Therefore, this rationale is reflected the project title: "You cannot change your family history, but you can change what you do with it: A peer-based education program to reduce breast cancer risk in African American women" This study will develop and test an educational curriculum that highlights the importance of knowing family history and sharing it with health care providers. The curriculum will include tools to gather family history and discuss it with providers to guide the delivery of care. The investigators will assess the effectiveness of the curriculum in group and one-on-one settings and when delivered by a Patient Ambassador (peer train-the trainer model) or a researcher. The specific objectives of the study are to: Obj. 1: Develop a CBPR-based curriculum- using a community based participatory research (CBPR) approach, that highlights the importance of family history as a risk factor for breast cancer that includes tools to collect family history information and discuss it with providers to enable a family history based screening regimen. Obj. 2: Train Patient Ambassadors- Patient Ambassadors, women from the community who act as community messengers to deliver the curriculum. Obj. 3: Pilot Implementation and Extensive Evaluation of the Curriculum- Assess two modes of delivery, group vs one-on-one, and Peer Ambassadors vs. a researcher. Obj. 4: Dissemination- of the curricular products, implementation pilot results, and implementation guides for communities and practices- via publications and other channels in preparation for grant submits to enhance the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Knowledge of Genetic Screening for Breast Cancer
Change intention to be screened and to gather family history and share with providers

Trial Design

4Treatment groups
Active Control
Group I: Researcher-GroupActive Control1 Intervention
Education delivered in a group session by a member of the research team
Group II: Research-One on OneActive Control1 Intervention
Education delivered telephonically one-on-one by a member of the research team
Group III: Patient Ambassador-GroupActive Control2 Interventions
Education delivered in a group session by a Patient Ambassador (a peer mentor)
Group IV: Patient Ambassador- One on OneActive Control2 Interventions
Education delivered telephonically one-on-one by a Patient Ambassador (peer mentor)

Find a Location

Who is running the clinical trial?

State University of New York at BuffaloLead Sponsor
245 Previous Clinical Trials
49,272 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~50 spots leftby Mar 2025